Clinical Trials Directory

Trials / Conditions / Primary Peritoneal

Primary Peritoneal

8 registered clinical trials studyying Primary Peritoneal — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingDrug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or
NCT07402915
AstraZenecaPhase 1
RecruitingA Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanc
NCT06682988
AbbViePhase 2
RecruitingStudy of IBI354 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Ovarian, Prim
NCT06834672
Innovent Biologics (Suzhou) Co. Ltd.Phase 3
Not Yet RecruitingJSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer
NCT06751485
Jiangsu Alphamab Biopharmaceuticals Co., LtdPhase 3
RecruitingCATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
NCT06690775
TORL Biotherapeutics, LLCPhase 2
Active Not RecruitingA Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Respo
NCT03522246
pharmaand GmbHPhase 3
CompletedIntraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreduct
NCT01826227
Memorial Sloan Kettering Cancer CenterN/A
WithdrawnSafety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary
NCT01131039
Emory UniversityPhase 2